Literature DB >> 9529062

The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets.

W J Lee1, J L Farmer, M Hilty, Y B Kim.   

Abstract

The unique germfree, colostrum-deprived, immunologically "virgin" piglet model was used to evaluate the ability of lactoferrin (LF) to protect against lethal shock induced by intravenously administered endotoxin. Piglets were fed LF or bovine serum albumin (BSA) prior to challenge with intravenous Escherichia coli lipopolysaccharide (LPS), and temperature, clinical symptoms, and mortality were tracked for 48 h following LPS administration. Prefeeding with LF resulted in a significant decrease in piglet mortality compared to feeding with BSA (16.7 versus 73.7% mortality, P < 0.001). Protection against the LPS challenge by LF was also correlated with both resistance to induction of hypothermia by endotoxin and an overall increase in wellness, as quantified by a toxicity score developed for these studies. In vitro studies using a flow cytometric assay system demonstrated that LPS binding to porcine monocytes was inhibited by LF in a dose-dependent fashion, suggesting that the mechanism of LF action in vivo may be inhibition of LPS binding to monocytes/macrophages and, in turn, prevention of induction of monocyte/macrophage-derived inflammatory-toxic cytokines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529062      PMCID: PMC108069     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Killing of gram-negative bacteria by lactoferrin and lysozyme.

Authors:  R T Ellison; T J Giehl
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

Review 2.  The role of lactoferrin as an anti-inflammatory molecule.

Authors:  B E Britigan; J S Serody; M S Cohen
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

Review 3.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

4.  Relationship between antibacterial activity and porin binding of lactoferrin in Escherichia coli and Salmonella typhimurium.

Authors:  S S Naidu; U Svensson; A R Kishore; A S Naidu
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

5.  Lactoferrin is a lipid A-binding protein.

Authors:  B J Appelmelk; Y Q An; M Geerts; B G Thijs; H A de Boer; D M MacLaren; J de Graaff; J H Nuijens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo.

Authors:  M Machnicki; M Zimecki; T Zagulski
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

7.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

8.  Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.

Authors:  E Elass-Rochard; A Roseanu; D Legrand; M Trif; V Salmon; C Motas; J Montreuil; G Spik
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

9.  Circulating tumor necrosis factor-alpha does not mediate endotoxin-induced hypothermia in rats.

Authors:  K Schotanus; G M Holtkamp; N van Rooijen; F J Tilders; F Berkenbosch
Journal:  Am J Physiol       Date:  1995-04

10.  Lipopolysaccharide-inactivating activity of neutrophils is due to lactoferrin.

Authors:  D Wang; K M Pabst; Y Aida; M J Pabst
Journal:  J Leukoc Biol       Date:  1995-06       Impact factor: 4.962

View more
  23 in total

1.  Plasma protein profiles of neonatal pigs before and after suckling.

Authors:  Yanyun Huang; Douglas J Olson; John R Gordon; Dorothy M Middleton; Elemir Simko
Journal:  Can J Vet Res       Date:  2012-01       Impact factor: 1.310

Review 2.  Lactoferrin and prematurity: a promising milk protein?

Authors:  Theresa J Ochoa; Stéphane V Sizonenko
Journal:  Biochem Cell Biol       Date:  2016-10-26       Impact factor: 3.626

3.  Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice.

Authors:  M L Kruzel; Y Harari; C Y Chen; G A Castro
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

4.  Attenuation of massive cytokine response to the staphylococcal enterotoxin B superantigen by the innate immunomodulatory protein lactoferrin.

Authors:  J L Hayworth; K J Kasper; M Leon-Ponte; C A Herfst; D Yue; W C Brintnell; D M Mazzuca; D E Heinrichs; E Cairns; J Madrenas; D W Hoskin; J K McCormick; S M M Haeryfar
Journal:  Clin Exp Immunol       Date:  2009-07       Impact factor: 4.330

5.  Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.

Authors:  D Caccavo; A Afeltra; S Pece; G Giuliani; M Freudenberg; C Galanos; E Jirillo
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.

Authors:  Ellen A J Thomassen; Harrie A van Veen; Patrick H C van Berkel; Jan H Nuijens; Jan Pieter Abrahams
Journal:  Transgenic Res       Date:  2005-08       Impact factor: 2.788

7.  Evaluation of the protective effect of bovine lactoferrin against lipopolysaccharides in a bovine mammary epithelial cell line.

Authors:  Chiara Pecorini; Davide Sassera; Raffaella Rebucci; Francesca Saccone; Claudio Bandi; Antonella Baldi
Journal:  Vet Res Commun       Date:  2010-03-30       Impact factor: 2.459

8.  Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme.

Authors:  Nidia León-Sicairos; Fernando López-Soto; Magda Reyes-López; Delfino Godínez-Vargas; Cynthia Ordaz-Pichardo; Mireya de la Garza
Journal:  Clin Med Res       Date:  2006-06

Review 9.  Lactoferrin for prevention of neonatal sepsis.

Authors:  Christie G Turin; Alonso Zea-Vera; Alonso Pezo; Karen Cruz; Jaime Zegarra; Sicilia Bellomo; Luis Cam; Raul Llanos; Anne Castañeda; Lourdes Tucto; Theresa J Ochoa
Journal:  Biometals       Date:  2014-06-17       Impact factor: 2.949

10.  Lactoferrin impairs type III secretory system function in enteropathogenic Escherichia coli.

Authors:  Theresa J Ochoa; Marita Noguera-Obenza; Frank Ebel; Carlos A Guzman; Henry F Gomez; Thomas G Cleary
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.